サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597167

アジア太平洋地域の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別

Asia Pacific Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
アジア太平洋地域の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別
出版日: 2024年10月03日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の臨床リファレンスラボ市場は、2023年には98億1,413万米ドルと評価され、2031年には165億1,017万米ドルに達すると予測され、2023年から2031年までのCAGRは6.7%と推定されます。

検査施設による戦略的取り組みがアジア太平洋地域の臨床リファレンスラボ市場を後押し

リファレンスラボとの買収、提携、拡大といった検査サービスプロバイダーによる戦略的イニシアチブは、より良い患者ケアとコスト効率という利益を得るための最も費用対効果の高い方法の一つです。2024年には、Hausen-Bernstein Co.Ltd.は、タイにおける体外診断用医薬品（IVD）のリーディングサプライヤーであり、インドおよび東南アジアにおけるマーケットアクセスおよび流通ビジネスで著名なEverlife Holdings Pte Ltd.に買収されました。2024年、インドを拠点とする薬剤選択と疾患層別化のための次世代診断薬であるCOREダイアグノスティックスは、新たに50都市で事業を拡大する計画を発表。2023年、Suburban DiagnosticsがムンバイのVidya Viharに最大規模の「リファレンス」ラボを開設。この超近代的な検査室では、最先端の検査技術とプロセス自動化技術を活用し、正確かつ迅速な診断のための包括的な検査メニューを提供します。2023年、インドのハイデラバードにある臨床リファレンスラボ、TRUSTlab Diagnosticsは、グルグラムにあるNKV Path Labsと提携し、国内の十分なサービスを受けていない地域に診断サービスを拡大しました。このように、リファレンスラボの買収や提携の増加は、市場成長に大きな機会を提供すると期待されています。

アジア太平洋地域の臨床リファレンスラボ市場概要

ここ数十年、COVID-19やサル痘を含むいくつかの感染症が出現し、人間の健康に新たなリスクをもたらしています。中国は急速な疫学的変化を経験しており、感染症対策が顕著に進歩しています。感染症の懸念に対処する場合、感染の拡大を最小限に抑え、感染症を予防・管理するために、できるだけ早く発生を発見し、場所を特定し、病原体を特定し、適切な処分を確保することが重要です。病原体を検出するために、病院や基準検査室でさまざまな検査が行われます。省レベル行政区分（PLADs）によると、2014年から2021年の間に5,770件のマラリア症例が記録され、99.05％のマラリアの検体が省マラリア診断基準検査室に提出されました。地方のマラリア診断基準検査室は、ヘルスケア施設における原虫診断の正確性と信頼性を保証する上で重要な役割を果たしています。上記の要因が、同国の臨床リファレンスラボ市場を牽引しています。

アジア太平洋地域の臨床リファレンスラボ市場の収益と2031年までの予測（百万米国ドル）

アジア太平洋地域の臨床リファレンスラボ市場セグメンテーション

アジア太平洋地域の臨床リファレンスラボ市場は、サービスプロバイダー、用途、国に分類されます。

サービスプロバイダーに基づき、アジア太平洋地域の臨床リファレンスラボ市場は病院ベース、スタンドアロン、クリニックベースに区分されます。病院ベースのセグメントが2023年に最大の市場シェアを占めました。

用途別では、アジア太平洋地域の臨床リファレンスラボ市場は検査薬、臨床試験、その他に分類されます。2023年には臨床リファレンスラボ部門が最大の市場シェアを占めました。

国別では、アジア太平洋地域の臨床リファレンスラボ市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2023年のアジア太平洋地域の臨床リファレンスラボ市場シェアは中国が独占しました。

Sonic Healthcare Ltd、Laboratory Corp of America Holdings、Quest Diagnostics Inc、Myraid Genetics Incは、アジア太平洋地域の臨床リファレンスラボ市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アジア太平洋地域の主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域の臨床リファレンスラボ市場- 主な市場力学

  • 市場促進要因
    • 慢性疾患および感染症の有病率の上昇
    • 臨床試験数の増加
  • 市場抑制要因
    • 規制の枠組みや継続的な技術開発の採用に関する問題
  • 市場機会
    • リファレンスラボとの戦略的イニシアティブ
  • 今後の動向
    • 臨床リファレンスラボにおける人工知能の利用
  • 促進要因と抑制要因の影響

第5章 臨床リファレンスラボ市場：アジア太平洋地域の分析

  • 臨床リファレンスラボ市場の収益、2021年～2031年
  • 臨床リファレンスラボ市場の予測と分析

第6章 臨床リファレンスラボ市場分析：サービスプロバイダー別

  • 病院
  • 独立型
  • クリニック

第7章 アジア太平洋地域の臨床リファレンスラボ市場分析：用途別

  • 臨床検査
  • 臨床試験
  • その他

第8章 アジア太平洋地域の臨床リファレンスラボ市場：国別分析

    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • アジア太平洋地域のその他諸国

第9章 臨床リファレンスラボ市場-業界情勢

  • 臨床リファレンスラボ市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第10章 企業プロファイル

  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • Myraid Genetics Inc

第11章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Clinical Reference Laboratory Market Segmentation
  • Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 4. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 6. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 7. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 8. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 10. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 12. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 13. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 14. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 16. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 17. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Clinical Reference Laboratory Market Segmentation, by Country
  • Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Asia Pacific: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 14. Asia Pacific: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 15. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Growth Strategies in the Clinical Reference Laboratory Market
目次
Product Code: BMIRE00030828

The Asia Pacific clinical reference laboratory market was valued at US$ 9,814.13 million in 2023 and is expected to reach US$ 16,510.17 million by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031.

Strategic Initiatives with Reference Laboratories Boost Asia Pacific Clinical Reference Laboratory Market

Strategic initiatives by the laboratory service providers such as acquisition, alliance, and expansion with reference labs are among the most cost-effective ways to obtain the benefits of better patient care and cost efficiency. In 2024, Hausen-Bernstein Co. Ltd., the leading supplier of in-vitro diagnostic ("IVD") products in Thailand, was acquired by Everlife Holdings Pte Ltd, a prominent market access and distribution business in India and Southeast Asia. In 2024, CORE Diagnostics, a next-generation diagnostics for medication selection and disease stratification based in India, announced its plans to expand operations in 50 new cities. In 2023, Suburban Diagnostics opened its largest 'reference' laboratory in Vidya Vihar, Mumbai. This ultramodern laboratory will utilize state-of-the-art testing and process automation technologies to provide a comprehensive test menu for accurate and quick diagnosis. In 2023, TRUSTlab Diagnostics, a clinical reference laboratory in Hyderabad, India, partnered with NKV Path Labs in Gurugram to expand its diagnostic services to underserved areas of the nation. Thus, the increasing number of acquisitions and alliances with reference laboratories is expected to offer significant opportunities for market growth.

Asia Pacific Clinical Reference Laboratory Market Overview

In recent decades, the emergence of several infectious illnesses, including COVID-19 and monkeypox, has posed a new risk to human health. China has experienced a rapid epidemiological change, with notable advances in infectious disease control. When dealing with infectious disease concerns, it is critical to detect and locate the outbreak as soon as possible, identify the pathogen, and ensure proper disposal to minimize escalation and prevent and manage infectious diseases. Various tests are done in hospitals or reference laboratories to detect the pathogen. According to the provincial-level administrative divisions (PLADs), 5,770 malaria cases were recorded between 2014 and 2021, with 99.05% samples of malaria submitted to provincial malaria diagnosis reference laboratories. Provincial malaria diagnosis reference laboratories have played a critical role in guaranteeing the accuracy and reliability of Plasmodium diagnosis in healthcare facilities. The abovementioned factors are driving the clinical reference laboratory market in the country.

Asia Pacific Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Clinical Reference Laboratory Market Segmentation

The Asia Pacific clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the Asia Pacific clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the Asia Pacific clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the Asia Pacific clinical reference laboratory market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, and Myraid Genetics Inc are some of the leading companies operating in the Asia Pacific clinical reference laboratory market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Clinical Reference Laboratory Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Increasing Number of Clinical Trials
  • 4.2 Market Restraints
    • 4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives with Reference Laboratories
  • 4.4 Future Trends
    • 4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
  • 4.5 Impact of Drivers and Restraints:

5. Clinical Reference Laboratory Market - Asia Pacific Analysis

  • 5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • 5.2 Clinical Reference Market Forecast and Analysis

6. Clinical Reference Laboratory Market Analysis - by Service Provider

  • 6.1 Overview
  • 6.2 Hospital-Based
    • 6.2.1 Overview
    • 6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Standalone
    • 6.3.1 Overview
    • 6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Clinical Based
    • 6.4.1 Overview
    • 6.4.2 Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Clinical Reference Laboratory Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Laboratory Medicine
    • 7.2.1 Overview
    • 7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Trials
    • 7.3.1 Overview
    • 7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Clinical Reference Laboratory Market - Country Analysis

  • 8.1 Asia Pacific Clinical Reference Laboratory Market Overview
    • 8.1.1 Asia Pacific: Clinical Reference Laboratory Market Breakdown 2023 and 2031 (%) - by Country
      • 8.1.1.1 China: Clinical Reference Laboratory Market - Overview
      • 8.1.1.2 China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 China: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.2.2 China: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.3 Japan: Clinical Reference Laboratory Market - Overview
      • 8.1.1.4 Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Japan: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.4.2 Japan: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.5 India: Clinical Reference Laboratory Market - Overview
      • 8.1.1.6 India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 India: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.6.2 India: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.7 Australia: Clinical Reference Laboratory Market - Overview
      • 8.1.1.8 Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.8.1 Australia: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.8.2 Australia: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.9 South Korea: Clinical Reference Laboratory Market - Overview
      • 8.1.1.10 South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.10.1 South Korea: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.10.2 South Korea: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.11 Rest of APAC: Clinical Reference Laboratory Market - Overview
      • 8.1.1.12 Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.12.1 Rest of APAC: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.12.2 Rest of APAC: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application

9. Clinical Reference Laboratory Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Clinical Reference Laboratory Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Sonic Healthcare Ltd
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Laboratory Corp of America Holdings
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Quest Diagnostics Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Myraid Genetics Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms